Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Pennant Group, Inc.PNTG · Entity 4774 | Chief Clinical Officer | August 06, 2026 | August 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Pennant Group, Inc.
Report date August 06, 2026 · Filed August 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,106 |
Reported balance
After 2026-08-06 transaction · row 1
1 source rowRow 1 · 2026-08-06 · Sale · Disposed 1,394 · Balance 15,106 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 06, 2026 Filed Aug 10, 2026 19:48 UTC | Pennant Group, Inc. PNTG · Entity 4774 | SaleCommon Stock | 1,394 | $38.52 | $53,699.67 |
DisclosureSEC source: 0002078374-26-000003 · wk-form4_1786391323.xml · nonDerivative · entry 1 Steik Jason Paul · CIK 0002078374 · Chief Clinical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,106 Read SEC document |
| March 05, 2026 Filed Mar 12, 2026 19:14 UTC | Pennant Group, Inc. PNTG · Entity 4774 | GrantStock Option (right to buy) · Derivative | 26,000 | $33.30 Strike: $33.30 | $865,800.00 |
DisclosureSEC source: 0001766400-26-000021 · wk-form4_1773342846.xml · derivative · entry 1 Steik Jason Paul · CIK 0002078374 · Chief Clinical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,000 Underlying: Common Stock · 26,000 shares Expires 2036-03-05 F1 · shares: These shares vest in five equal annual installments beginning March 5, 2027. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.